Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 105

1.

[Update on current care guidelines. Diagnosis, treatment and follow-up of cytological changes in the cervix, vagina and vulva].

Pekka N, Anttila A, Bützow R, Heikkilä E, Hiltunen-Back E, Mäenpää J, Puistola U, Rantanen V, Rintala M, Räisänen I, Santalahti A, Talvensaari-Mattila A, Vartiainen J, Vuento M, Yliskoski M; Suomalaisen Lääkäriseuran Duodecimin ja Suomen Kolposkopiayhdistyksen Asettama Työryhmä..

Duodecim. 2010;126(16):1965-6. Finnish. Erratum in: Duodecim. 2010;126(17):2078. Rintala, Marjut [added].

PMID:
20957796
2.

Baseline cytology, human papillomavirus testing, and risk for cervical neoplasia: a 10-year cohort analysis.

Sherman ME, Lorincz AT, Scott DR, Wacholder S, Castle PE, Glass AG, Mielzynska-Lohnas I, Rush BB, Schiffman M.

J Natl Cancer Inst. 2003 Jan 1;95(1):46-52.

PMID:
12509400
3.

Risk-adapted primary HPV cervical cancer screening project in Wolfsburg, Germany--experience over 3 years.

Luyten A, Scherbring S, Reinecke-Lüthge A, Braun BE, Pietralla M, Theiler K, Petry KU.

J Clin Virol. 2009 Nov;46 Suppl 3:S5-10. doi: 10.1016/S1386-6532(09)70294-X.

PMID:
20129072
4.

European guidelines for quality assurance in cervical cancer screening: recommendations for clinical management of abnormal cervical cytology, part 1.

Jordan J, Arbyn M, Martin-Hirsch P, Schenck U, Baldauf JJ, Da Silva D, Anttila A, Nieminen P, Prendiville W.

Cytopathology. 2008 Dec;19(6):342-54. doi: 10.1111/j.1365-2303.2008.00623.x.

PMID:
19040546
5.

Determination of the diagnostic accuracy of testing for high-risk (HR) human papillomavirus (HPV) types 16, 18 and 45 in precancerous cervical lesions: preliminary data.

Tiews S, Steinberg W, Schneider W, Hanrath C.

J Clin Virol. 2009 Nov;46 Suppl 3:S11-5. doi: 10.1016/S1386-6532(09)70295-1.

PMID:
20129068
6.

[Cervical cancer screening: past--present--future].

Breitenecker G.

Pathologe. 2009 Dec;30 Suppl 2:128-35. doi: 10.1007/s00292-009-1189-1. German.

PMID:
19756616
7.
8.

Cervical cancer screening. Organised screening to avoid unnecessary conisation.

[No authors listed]

Prescrire Int. 2010 Aug;19(108):172-7, 179. Review.

PMID:
20939454
9.

Human papillomavirus testing in primary cervical screening and abnormal Papanicolaou management.

Cox JT.

Obstet Gynecol Surv. 2006 Jun;61(6 Suppl 1):S15-25. Review.

PMID:
16729900
10.

Virologic versus cytologic triage of women with equivocal Pap smears: a meta-analysis of the accuracy to detect high-grade intraepithelial neoplasia.

Arbyn M, Buntinx F, Van Ranst M, Paraskevaidis E, Martin-Hirsch P, Dillner J.

J Natl Cancer Inst. 2004 Feb 18;96(4):280-93.

PMID:
14970277
11.

Present standards for cervical cancer screening.

O'Meara AT.

Curr Opin Oncol. 2002 Sep;14(5):505-11. Review.

PMID:
12192269
13.

Comparing PAP smear cytology, aided visual inspection, screening colposcopy, cervicography and HPV testing as optional screening tools in Latin America. Study design and baseline data of the LAMS study.

Syrjänen K, Naud P, Derchain S, Roteli-Martins C, Longatto-Filho A, Tatti S, Branca M, Erzen M, Hammes LS, Matos J, Gontijo R, Sarian L, Braganca J, Arlindo FC, Maeda MY, Lörincz A, Dores GB, Costa S, Syrjänen S.

Anticancer Res. 2005 Sep-Oct;25(5):3469-80.

15.

[Human papillomavirus typing in routine cervical smears. Results from a series of 3778 patients].

Levert M, Clavel C, Graesslin O, Masure M, Birembaut P, Quereux C, Gabriel R.

Gynecol Obstet Fertil. 2000 Oct;28(10):722-8. French.

PMID:
11244634
16.

Cost of screening and treatment of cervical dyskaryosis in Germany.

Petry KU, Breugelmans JG, Bénard S, Lamure E, Littlewood KJ, Hillemanns P.

Eur J Gynaecol Oncol. 2008;29(4):345-9.

PMID:
18714567
17.

Triage of women with atypical squamous cells of undetermined significance (ASC-US): results of an Italian multicentric study.

Del Mistro A, Frayle-Salamanca H, Trevisan R, Matteucci M, Pinarello A, Zambenedetti P, Buoso R, Fantin GP, Zorzi M, Minucci D.

Gynecol Oncol. 2010 Apr;117(1):77-81. doi: 10.1016/j.ygyno.2010.01.003.

PMID:
20116836
18.
19.

[Management of CIN1].

Rouzier R.

J Gynecol Obstet Biol Reprod (Paris). 2008 Feb;37 Suppl 1:S114-20. doi: 10.1016/j.jgyn.2007.11.017. Review. French.

20.

Prediction of recurrence after treatment for high-grade cervical intraepithelial neoplasia: the role of human papillomavirus testing and age at conisation.

Verguts J, Bronselaer B, Donders G, Arbyn M, Van Eldere J, Drijkoningen M, Poppe W.

BJOG. 2006 Nov;113(11):1303-7.

Supplemental Content

Support Center